ANAPTYSBIO, INC Annual Operating Income (Loss) in USD from 2015 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Anaptysbio, Inc quarterly/annual Operating Income (Loss) history and growth rate from 2015 to 2023.
  • Anaptysbio, Inc Operating Income (Loss) for the quarter ending September 30, 2024 was -$22.8M, a 39.7% increase year-over-year.
  • Anaptysbio, Inc Operating Income (Loss) for the twelve months ending September 30, 2024 was -$147M, a 0.56% increase year-over-year.
  • Anaptysbio, Inc annual Operating Income (Loss) for 2023 was -$164M, a 42.8% decline from 2022.
  • Anaptysbio, Inc annual Operating Income (Loss) for 2022 was -$115M, a 103% decline from 2021.
  • Anaptysbio, Inc annual Operating Income (Loss) for 2021 was -$56.8M, a 138% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$164M -$49.3M -42.8% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-11
2022 -$115M -$58.3M -103% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-11
2021 -$56.8M -$32.9M -138% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-11
2020 -$23.9M +$83.6M +77.8% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-01
2019 -$107M -$40.7M -61% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-07
2018 -$66.7M -$37.9M -132% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-25
2017 -$28.8M -$25.8M -851% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-02
2016 -$3.03M +$297K +8.94% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-28
2015 -$3.32M Jan 1, 2015 Dec 31, 2015 10-K 2018-03-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.